Advertisement

On the cusp of going public, BG Medicine Inc. has pulled its IPO, Dow Jones reports.

BG, which is developing a cardiac diagnostic test, initially filed to go public in January with plans for an $86.3 million offering. BG scaled back those plans twice before pulling the plug — last week, when the company was reportedly aiming for a $71.2 million offering, and this week, when BG announced plans to go public with 4.75 million shares priced between $13 and $15 — a total offering of about $60 million. 

SOURCE

Advertisement
Advertisement